Biggest News Aggregation in the World
📰 Roivant Sciences News

Roivant Sciences News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Roivant Sciences. Real-time updates on events, politics, business and more.

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024

29.05.2024 - Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic areas over this fiscal year ...
Chau Cheng Exchange Commission Neurology Clinical Development Updates Due To Roivant Sciences Ltd General Clinical Development Updates Endocrinology Clinical Development Updates

Institutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV)

We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss why institutional investors are bullish on Roivant Sciences Ltd. (NASDAQ:ROIV). Challenges in the Health Sector The healthcare industry is considered to be a fairly defensive sector due to its need. According to a World […]
Piper Sandler Allison Bratzel Number Of Hedge Fund Holders Roivant Sciences Ltd Energy Stocks To Buy According Analysts Roivant Sciences
Source: yahoo.com

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. […]
Principal Financial Group Inc Roivant Sciences Analyst Recommendations For Roivant Sciences Deutsche Bank Aktiengesellschaft Roivant Sciences Ltd Allspring Global Investments Holdings
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Vivek Ramaswamy: How A Startup Prodigy Built His Billion-Dollar Empire

The famous biotech entrepreneur Vivek Ramaswamy has dropped out of the 2024 US presidential race and is endorsing former President Donald Trump. This decision of Vivek Ramaswamy left many of the supporters wondering about the reasons for his departure from this presidential race.
United States White House District Of Columbia Xavier High School Andaman And Nicobar Islands Ron Desantis

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science